Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Raw Materials: 2018-2019

  • Niagen Bioscience's Raw Materials fell 39.49% to $1.4 million in Q4 2019 from the same period last year, while for Dec 2019 it was $1.4 million, marking a year-over-year decrease of 39.49%. This contributed to the annual value of $1.4 million for FY2019, which is 39.49% down from last year.
  • According to the latest figures from Q4 2019, Niagen Bioscience's Raw Materials is $1.4 million, which was down 39.49% from $2.3 million recorded in Q4 2018.
  • Niagen Bioscience's 5-year Raw Materials high stood at $2.3 million for Q4 2018, and its period low was $1.4 million during Q4 2019.
  • Over the past 2 years, Niagen Bioscience's median Raw Materials value was $1.8 million (recorded in 2018), while the average stood at $1.8 million.
  • Data for Niagen Bioscience's Raw Materials shows a maximum YoY plummeted of 39.49% (in 2019) over the last 5 years.
  • Over the past 2 years, Niagen Bioscience's Raw Materials (Quarterly) stood at $2.3 million in 2018, then crashed by 39.49% to $1.4 million in 2019.